Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Feldmann

Showing results (51-60 of 157) with videos related to

Pageof 16
Sort By:
Clinical Medicine (London, England)|June 3, 2017
Developments in therapy with monoclonal antibodies and related proteinsH Michael Shepard, Gail Lewis Phillips, Christopher D Thanos, et al.
Journal of Cell Science|January 23, 2003
VEGF expression in human macrophages is NF-kappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2Serafim Kiriakidis, Evangelos Andreakos, Claudia Monaco, et al.
Nature Reviews. Rheumatology|November 3, 2023
25 years of biologic DMARDs in rheumatologyMarc Feldmann, Ravinder N Maini, Enrique R Soriano, et al.
Expert Reviews in Molecular Medicine|August 25, 2005
Molecular therapeutic targets in rheumatoid arthritisSandra M Sacre, Evangelos Andreakos, Peter Taylor, et al.
Arthritis Research & Therapy|August 8, 2012
Differential effects of Th1 versus Th2 cytokines in combination with hypoxia on HIFs and angiogenesis in RAHelene Larsen, Barbara Muz, Tak L Khong, et al.
Arthritis Research & Therapy|April 30, 2003
The angiogenesis inhibitor protease-activated kringles 1-5 reduces the severity of murine collagen-induced arthritisPercy F Sumariwalla, Yihai Cao, Hua-Lin Wu, et al.
Arthritis and Rheumatism|March 17, 2004
A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritisPercy F Sumariwalla, Ruth Gallily, Susanna Tchilibon, et al.
Cytokine|September 3, 2004
Advanced glycation end products upregulate angiogenic and pro-inflammatory cytokine production in human monocyte/macrophagesMagdalena Pertyńska-Marczewska, Serafim Kiriakidis, Robin Wait, et al.
Cytokine & Growth Factor Reviews|September 11, 2002
Cytokines and anti-cytokine biologicals in autoimmunity: present and futureEvangelos T Andreakos, Brian M Foxwell, Fionula M Brennan, et al.
Arthritis and Rheumatism|April 3, 2008
CD200-Fc, a novel antiarthritic biologic agent that targets proinflammatory cytokine expression in the joints of mice with collagen-induced arthritisEgle Simelyte, Gabriel Criado, David Essex, et al.
Pageof 16

Showing results (51-60 of 157) with videos related to

Sort By:
Pageof 16
Clinical Medicine (London, England)|June 3, 2017
Developments in therapy with monoclonal antibodies and related proteinsH Michael Shepard, Gail Lewis Phillips, Christopher D Thanos, et al.
Journal of Cell Science|January 23, 2003
VEGF expression in human macrophages is NF-kappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2Serafim Kiriakidis, Evangelos Andreakos, Claudia Monaco, et al.
Nature Reviews. Rheumatology|November 3, 2023
25 years of biologic DMARDs in rheumatologyMarc Feldmann, Ravinder N Maini, Enrique R Soriano, et al.
Expert Reviews in Molecular Medicine|August 25, 2005
Molecular therapeutic targets in rheumatoid arthritisSandra M Sacre, Evangelos Andreakos, Peter Taylor, et al.
Arthritis Research & Therapy|August 8, 2012
Differential effects of Th1 versus Th2 cytokines in combination with hypoxia on HIFs and angiogenesis in RAHelene Larsen, Barbara Muz, Tak L Khong, et al.
Arthritis Research & Therapy|April 30, 2003
The angiogenesis inhibitor protease-activated kringles 1-5 reduces the severity of murine collagen-induced arthritisPercy F Sumariwalla, Yihai Cao, Hua-Lin Wu, et al.
Arthritis and Rheumatism|March 17, 2004
A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritisPercy F Sumariwalla, Ruth Gallily, Susanna Tchilibon, et al.
Cytokine|September 3, 2004
Advanced glycation end products upregulate angiogenic and pro-inflammatory cytokine production in human monocyte/macrophagesMagdalena Pertyńska-Marczewska, Serafim Kiriakidis, Robin Wait, et al.
Cytokine & Growth Factor Reviews|September 11, 2002
Cytokines and anti-cytokine biologicals in autoimmunity: present and futureEvangelos T Andreakos, Brian M Foxwell, Fionula M Brennan, et al.
Arthritis and Rheumatism|April 3, 2008
CD200-Fc, a novel antiarthritic biologic agent that targets proinflammatory cytokine expression in the joints of mice with collagen-induced arthritisEgle Simelyte, Gabriel Criado, David Essex, et al.
Pageof 16